A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study

1. Gavilá, J.
2. De La Haba, J.
3. Bermejo, B.
4. Rodríguez-Lescure, Á.
5. Antón, A.
6. Ciruelos, E.
7. Brunet, J.
8. Muñoz-Couselo, E.
9. Santisteban, M.
10. Rodríguez Sánchez, C.A.
11. Santaballa, A.
12. Sánchez Rovira, P.
13. García Sáenz, J.Á.
14. Ruiz-Borrego, M.
15. Guerrero-Zotano, A.L.
16. Huerta, M.
17. Cotes-Sanchís, A.
18. Lao Romera, J.
19. Aguirre, E.
20. Cortés, J.
21. Llombart-Cussac, A.